Article
Dennis P. Scanlon, PhD, faculty member and health services researcher at Penn State University, and associate editor of The American Journal of Managed Care, leads a discussion on diabetes and patient care management that is concentrated on patient behavior, patient motivation, and ultimately, patient adherence. He is joined by Paul Ciechanowski, MD, MPH; Todd Prewitt, MD, FAAFP; Trishan Panch, MD, MPH; and Ronal Tamler, MD, PhD, MBA, CDE.
%jwplayer%
Dennis P. Scanlon, PhD, faculty member and health services researcher at Penn State University, and associate editor of The American Journal of Managed Care, leads a discussion on diabetes and patient care management that is concentrated on patient behavior, patient motivation, and ultimately, patient adherence. He is joined by Paul Ciechanowski, MD, MPH; Todd Prewitt, MD, FAAFP; Trishan Panch, MD, MPH; and Ronal Tamler, MD, PhD, MBA, CDE.
When it comes to patient adherence, Dr Ciechanowski says that medication adherence is simply a form of behavior change, whether it takes shape in a lifestyle change or in a change of self-management. The Multi-Condition Collaborative Care Model that he implements in his own work is one that he believes elevates the importance of behavior change.
“There is a model that really does work where we combine elements of treatment to target and systematic case review, where we use a team approach and physician extenders,” Dr Ciechanowski says.
Dr Prewitt emphasizes a patient-centered approach, explaining that in the context of integrated delivery systems and adherence, the focus needs to come back to the patient. He explains that to achieve these objectives, the following questions need to be answered: “What are the patient’s goals, what are their desires for their health, and how do we align our programs to support some of their primary objectives.”
Dr Panch additionally suggests coupling human care and technology and applying this union to build clinical relationships by using technology to “amplify rather than replace.”
The panelists discuss the most effective ways to encourage patient behavior change as well as ways in which these methods can be implemented across the board from a payer perspective.
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
How Can Employers Leverage the DPP to Improve Diabetes Rates?
FDA Expands Omnipod 5 AID System Label to Treat Type 2 Diabetes